The FDA granted accelerated approval to Bristol-Myers’s skin-cancer treatment Opdivo, which uses the body’s immune system to fight tumors.
WSJ.com: What's News US, Wall Street Journal
Mon, 12/22/2014 - 1:38pm
The FDA granted accelerated approval to Bristol-Myers’s skin-cancer treatment Opdivo, which uses the body’s immune system to fight tumors.